Evidence map›Paper›PMID 41070991›Full record

ArticleMicrobiology spectrum2025

Streamlined extraction of nucleic acids and metabolites from low- and high-biomass samples using isopropanol and matrix tubes.

Caitriona Brennan, Justin P Shaffer, Pedro Belda-Ferre, Ipsita Mohanty, Yuhan Weng, Kalen Cantrell, Gail Ackermann, Celeste Allaband, MacKenzie Bryant, Sawyer Farmer and 12 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Caitriona Brennan *Department of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-3943-6701
Justin P Shaffer *Department of Biology, California State University, Fresno, California, USA.ORCID 0000-0002-9371-6336
Pedro Belda-FerreDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0001-6532-1161
Ipsita MohantyCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, California, USA.ORCID 0000-0001-5311-6443
Yuhan WengDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0009-0005-3453-1402
Kalen CantrellBioinformatics and Systems Biology Program, University of California San Diego, La Jolla, California, USA.
Gail AckermannDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-3901-4931
Celeste AllabandDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-1832-4858
MacKenzie BryantDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-0749-2995
Sawyer FarmerDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0009-0006-4160-9535
Antonio GonzálezDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.
Daniel McDonaldDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-0876-9060
Cameron MartinoDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.
Michael J MeehanCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, California, USA.ORCID 0000-0002-6836-0294
Gibraan RahmanDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-8843-0229
Rodolfo A SalidoDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0003-0631-2817
Tara SchwartzDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.
Se Jin SongCenter for Microbiome Innovation, University of California, San Diego, La Jolla, California, USA.ORCID 0000-0003-0750-5709
Caitlin TribelhornDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0009-0002-8788-471X
Helena M TubbDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-7637-5090
Pieter C DorresteinDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-3003-1030
Rob KnightDepartment of Pediatrics, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-0975-9019

Funding

Project 4 - Mechanistic studies on the role of the gut microbiome in models for Alzheimer's diseaseU19AG063744 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Rima F Kaddurah-Daouk · 2019 to 2026
$54.1M
UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunityDP1AT010885 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KNIGHT, ROB · 2019 to 2023
$5.5M
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
Common Fund U19AG063744, 1DP1AT010885NCCIH NIH HHS DP1 AT010885NIA NIH HHS U19 AG063744NIGMS NIH HHS K12 GM068524NIH HHS S10 OD026929Professors of the Future SD IRACDA - Professors of the Future - 5K12GM068524-17
6 · The paper itself

Abstract

An essential aspect of population-based research is collecting samples outside of a clinical setting. This is crucial because microbial populations are highly dynamic, varying significantly across hosts, environments, and time points, a variability that clinical sample collection alone cannot fully capture. At-home sample collection enables the inclusion of a larger and more diverse group of participants, accounting for differences in ethnicity, age, and other factors. However, managing large studies is challenging due to the complexities involved in sample acquisition, processing, and analysis. Building on our previous work demonstrating the effectiveness of single 1 mL barcoded, racked Matrix Tubes in reducing sample processing time and well-to-well contamination for paired DNA and metabolite extraction, we further validate this method against a previously benchmarked plate-based approach using the same extraction reagents. This validation focuses on samples from the built environment, human skin, human saliva, and feces from mice and humans. Importantly, we explore the impact of using a mix of bead sizes during bead-beating for cell lysis, demonstrating that it enhances taxonomic recovery compared to a single bead size. Finally, we assess the potential of 95% isopropanol for room-temperature sample preservation. Our results show that isopropanol performs comparably to 95% ethanol in many cases, suggesting it is viable as an alternative when ethanol is unavailable. Beyond minimizing contamination, halving processing time, eliminating human error during sample plating, and streamlining metadata curation, the Matrix tube approach produces metabolomic, 16S, and shotgun metagenomic data consistent with the Plate-based Method for both high- and low-biomass samples. IMPORTANCE: Numerous studies have linked the microbiome to human and environmental health, yet many fundamental questions remain unanswered. Large-scale studies with robust statistical power are required to identify important covariates against a background of confounding factors. Cross-contamination, limited throughput, and human error have been identified as major setbacks when processing large numbers of samples. We present a streamlined method for sample accession and extraction of metabolites and DNA for both high- and low-biomass samples. This approach, previously shown to significantly reduce cross-contamination, employs an automation-friendly, single barcoded tube per sample. Additionally, we demonstrate that 95% isopropanol serves as an effective ambient-temperature storage solution for many sample types, providing an alternative in regions where ethanol is unavailable or restricted. This method has significant implications for the field, enabling large-scale studies to generate accurate insights with greater efficiency and expanded accessibility in situations in which ethanol is more costly or otherwise not available.

Indexed as

2-PropanolNucleic AcidsSpecimen HandlingAnimalsBiomassFecesHumansMiceSaliva2-PropanolNucleic Acids16S rRNA geneautomationcontaminationlarge-scale studiesmetabolomicsmetagenomicsmicrobiomesample storagestudy design

Identifiers

PMID41070991
PMCPMC12584695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.